The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
case-study
Advancing Biotech Drug Development: Syner-G BioPharma’s Collaborative Approach to Chemistry, Manufacturing, and Controls
Read More
case-study
Synthesizing Success: Syner-G’s Strategic Solutions for Elevating a Biotech Innovator
Read More
case-study
Regulatory Expectations for Sterile Filtration Process Control
Read More
case-study
Strategic CMC Development Partnership Enabling Timely Approval and Launch of a Breakthrough Product
Read More
Let's move from science to success.
Let’s Talk